Aimovig vs. Ajovy

• Are Aimovig and Ajovy the Same Thing?
• What Are Possible Side Effects of Aimovig?
• What Are Possible Side Effects of Ajovy?
• What Is Aimovig?
• What Is Ajovy?
• What Drugs Interact with Aimovig?
• What Drugs Interact with Ajovy?
• How Should Aimovig Be Taken?
• How Should Ajovy Be Taken?

Aimovig (erenumab-aooe) and Ajovy (fremanezumab-vfrm) are calcitonin gene-related peptide receptor antagonists indicated for the preventive treatment of migraine in adults.

Common side effects of Aimovig include:

• injection site reactions (pain or redness),
• constipation, and
• muscle spasms or
• cramps

Common side effects of Ajovy include:

• injection site reactions (pain, swelling, and redness)

Aimovig (erenumab-aooe) Injection is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults.

Ajovy (fremanezumab-vfrm) is a calcitonin gene-related peptide antagonist indicated for the preventive treatment of migraine in adults.

Aimovig may interact with other drugs. Tell your doctor all medications and supplements you use.

Ajovy may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Ajovy; it is unknown how it would affect a fetus. It is unknown if Ajovy passes into breast milk. Consult your doctor before breastfeeding.

The recommended dosage of Aimovig is 70 mg once monthly; some patients may benefit from a dosage of 140 mg once monthly, which is administered as two consecutive subcutaneous injections of 70 mg each.

Two subcutaneous dosing options of Ajovy are available to administer the recommended dosage: 225 mg monthly, or 675 mg every 3 months (quarterly). The 675 mg quarterly dosage is administered as three consecutive injections of 225 mg each.